Modafinil
Scottish Health Purchasing Information Centre
Record ID 31998009127
English
Authors' objectives:
This report aims to assess the effectiveness of modafinil in the treatment of narcolepsy, a rare central nervous system disorder of unknown aetiology characterised by excessive daytime sleepiness (EDS).
Authors' recommendations:
This review concludes that: 1. It is recommended that treatment with modafinil should be initiated only by consultants (probably mainly in neurology or respiratory medicine) with expertise in narcolepsy.
2. Further research is necessary, including studies of long-term efficacy, tolerance and side-effects, and direct comparison with other drugs.
3. Patients should be tried on the older and cheaper drugs before modafinil.
4. In order to aid general practitioners in referral of patients with possible narcolepsy, a SIGN guideline should be produced.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.nhsconfed.net/shpic/doc16.htm
Year Published:
1998
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Costs and Cost Analysis
- Benzhydryl Compounds
- Central Nervous System Stimulants
- Narcolepsy
Contact
Organisation Name:
Scottish Health Purchasing Information Centre
Copyright:
Scottish Health Purchasing Information Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.